246 related articles for article (PubMed ID: 29723057)
1. Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease.
Rothnie KJ; Connell O; Müllerová H; Smeeth L; Pearce N; Douglas I; Quint JK
Ann Am Thorac Soc; 2018 Aug; 15(8):935-946. PubMed ID: 29723057
[TBL] [Abstract][Full Text] [Related]
2. Risk of Acute Myocardial Infarction and Ischemic Stroke in Patients with Asthma Exacerbation: A Population-Based, Self-Controlled Case Series Study.
Raita Y; Camargo CA; Faridi MK; Brown DFM; Shimada YJ; Hasegawa K
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):188-194.e8. PubMed ID: 31323338
[TBL] [Abstract][Full Text] [Related]
3. Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
Graul EL; Nordon C; Rhodes K; Marshall J; Menon S; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
Am J Respir Crit Care Med; 2024 Apr; 209(8):960-972. PubMed ID: 38127850
[No Abstract] [Full Text] [Related]
4. Increased risk of myocardial infarction and stroke following exacerbation of COPD.
Donaldson GC; Hurst JR; Smith CJ; Hubbard RB; Wedzicha JA
Chest; 2010 May; 137(5):1091-7. PubMed ID: 20022970
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.
Reilev M; Pottegård A; Lykkegaard J; Søndergaard J; Ingebrigtsen TS; Hallas J
Respirology; 2019 Dec; 24(12):1183-1190. PubMed ID: 31222861
[TBL] [Abstract][Full Text] [Related]
6. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.
Whittaker H; Rubino A; Müllerová H; Morris T; Varghese P; Xu Y; De Nigris E; Quint JK
Int J Chron Obstruct Pulmon Dis; 2022; 17():427-437. PubMed ID: 35264849
[TBL] [Abstract][Full Text] [Related]
7. No association between exacerbation frequency and stroke in patients with COPD.
Windsor C; Herrett E; Smeeth L; Quint JK
Int J Chron Obstruct Pulmon Dis; 2016; 11():217-25. PubMed ID: 26893553
[TBL] [Abstract][Full Text] [Related]
8. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Cohen DJ; Steg PG; Cannon CP; Apruzzese PK; D'Agostino RB; Massaro JM; Mauri L;
JAMA Cardiol; 2017 May; 2(5):478-487. PubMed ID: 28297015
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.
Rothnie KJ; Numbere B; Gelwicks S; Lu Y; Sharma R; Compton C; Ismaila AS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2023; 18():2673-2685. PubMed ID: 38022832
[TBL] [Abstract][Full Text] [Related]
10. Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.
Løkke A; Hilberg O; Lange P; Ibsen R; Telg G; Stratelis G; Lykkegaard J
Int J Chron Obstruct Pulmon Dis; 2023; 18():419-429. PubMed ID: 37034899
[TBL] [Abstract][Full Text] [Related]
11. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.
Müllerová H; Marshall J; de Nigris E; Varghese P; Pooley N; Embleton N; Nordon C; Marjenberg Z
Ther Adv Respir Dis; 2022; 16():17534666221113647. PubMed ID: 35894441
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.
Feary JR; Rodrigues LC; Smith CJ; Hubbard RB; Gibson JE
Thorax; 2010 Nov; 65(11):956-62. PubMed ID: 20871122
[TBL] [Abstract][Full Text] [Related]
13. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.
Oshagbemi OA; Keene SJ; Driessen JHM; Jordan R; Wouters EFM; de Boer A; de Vries F; Franssen FME
Respir Med; 2018 Nov; 144():1-6. PubMed ID: 30366578
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD.
Campo G; Pavasini R; Malagù M; Punzetti S; Napoli N; Guerzoni F; Papi A; Ceconi C; Contoli M
COPD; 2015; 12(5):560-7. PubMed ID: 25775224
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.
Fawzy A; Putcha N; Aaron CP; Bowler RP; Comellas AP; Cooper CB; Dransfield MT; Han MK; Hoffman EA; Kanner RE; Krishnan JA; Labaki WW; Paine R; Paulin LM; Peters SP; Wise R; Barr RG; Hansel NN;
Chest; 2019 Mar; 155(3):519-527. PubMed ID: 30593776
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
Patel AR; Kowlessar BS; Donaldson GC; Mackay AJ; Singh R; George SN; Garcha DS; Wedzicha JA; Hurst JR
Am J Respir Crit Care Med; 2013 Nov; 188(9):1091-9. PubMed ID: 24033321
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Exacerbation and Symptom-Free Time in Patients with COPD.
de Vries MI; Effing TW; van der Palen J; Schrijver J; van der Valk P; Lenferink A
COPD; 2023 Dec; 20(1):9-17. PubMed ID: 37552476
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
[TBL] [Abstract][Full Text] [Related]
19. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
[TBL] [Abstract][Full Text] [Related]
20. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
